Clinical Report: Language Barriers Linked to Cancer Treatment Delays
Overview
A Texas registry study found that treatment delays of 6 weeks or longer after diagnosis were linked to poorer overall survival in early age–onset colorectal cancer patients. Language barriers and minority status were identified as significant factors contributing to these treatment delays.
Background
Understanding treatment delays in cancer care is crucial as they can significantly impact patient outcomes. Early age–onset colorectal cancer (EOCRC) presents unique challenges, particularly among minority populations who may face additional barriers.
Data Highlights
The study analyzed data from 112,672 colorectal cancer patients diagnosed from 2004 to 2019, with a focus on 12,079 early age–onset cases.
Key Findings
Treatment delays of 6 weeks or longer were associated with poorer overall survival.
Patients with EOCRC were more likely to be Hispanic and present with metastatic disease compared to older patients.
Language barriers were linked to a 1.45 times higher odds of treatment delay in vulnerable neighborhoods.
Despite more advanced disease, EOCRC patients had better overall survival than average age–onset patients (hazard ratio = 0.73).
Male sex, left-sided tumors, and uninsured status were associated with higher odds of treatment delay.
Clinical Implications
Healthcare providers should be aware of the potential impact of language barriers on treatment timelines for colorectal cancer patients. Implementing strategies to improve communication and access for non-English speakers may enhance timely care and outcomes.
Conclusion
The findings highlight the importance of addressing language barriers in cancer care to reduce treatment delays and improve survival outcomes for vulnerable populations.
A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.
